shenzhen neptunus bioengineering (000078.SZ): the net income in the first three quarters was 46.2173 million yuan, a year-on-year decrease of 47.77%.

Gelonghui Finance · Oct 30 19:40

Gelonghui, October 30 | Haiwang Biotech (000078.SZ) released its report for the third quarter of 2024. The company achieved operating income of 24.553 billion yuan in the first three quarters, a year-on-year decrease of 14.27%; net profit attributable to shareholders of listed companies was 46.2173 million yuan, a year-on-year decrease of 47.77%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 19.7353 million yuan, a year-on-year decrease of 53.72%; basic earnings per share were 0.0176 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

海王生物(000078.SZ)：前三季度净利润4621.73万元 同比下降47.77%

shenzhen neptunus bioengineering (000078.SZ): the net income in the first three quarters was 46.2173 million yuan, a year-on-year decrease of 47.77%.

Risk Disclaimer

Statement

海王生物(000078.SZ)：前三季度净利润4621.73万元同比下降47.77%